THORATEC CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-10-30: Form 8-K; Period of report 2013-10-30; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2013-09-05: Form 8-K/A; Period of report 2013-09-05; Description 9.01 Financial Statements and Exhibits.
- 2013-07-31: Form 8-K; Period of report 2013-07-31; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2013-07-01: Form 8-K; Period of report 2013-06-30; Description 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 8.01 Other Events; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2013-10-30 | 8-K | 2013-10-30 | 2.02 Results of Operations and Financial Condition | 2.02 On October 30, 2013, Thoratec Corporation (the “Company”) issued a press release announcing its third quarter ended September 28, 2013 results, the text of which is attached hereto as Exhibit 99.1. | v358602_8k.htm |
| 2013-09-05 | 8-K/A | 2013-09-05 | 9.01 Financial Statements and Exhibits | a13-18342_18ka.htm | |
| 2013-07-31 | 8-K | 2013-07-31 | 2.02 Results of Operations and Financial Condition | 2.02 On July 31, 2013, Thoratec Corporation (the “Company”) issued a press release announcing its second quarter ended June 29, 2013 results, the text of which is attached hereto as Exhibit 99.1. | v351371_8k.htm |
| 2013-07-01 | 8-K | 2013-06-30 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 8.01 Other Events | 1.01 On June 30, 2013, Thoratec Corporation, a California corporation (“Thoratec”), entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with Terumo Corporation, a corporation formed pursuant to the laws of Japan (“Terumo Parent”), and Terumo Heart, Inc., a Delaware corporation (“THI,” and together with Terumo Parent, collectively, “Terumo”). 2.01 The information set forth in Item 1.01 is incorporated herein by reference. 8.01 On July 1, 2013, Thoratec issued a press release announcing that it had entered into the Asset Purchase Agreement and consummated the Acquisition. | a13-15932_18k.htm |
| 2013-05-24 | 8-K | 2013-05-22 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 At the Thoratec Corporation (the “Company”) Annual Meeting of Shareholders held on May 22, 2013 (the “Annual Meeting”), the shareholders of the Company voted on the following three proposals, each of which are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 9, 2013. | a13-13225_18k.htm |
| 2013-05-02 | 8-K | 2013-05-02 | 2.02 Results of Operations and Financial Condition | 2.02 On May 2, 2013, Thoratec Corporation (the “Company”) issued a press release announcing its first quarter ended March 30, 2013 results, the text of which is attached hereto as Exhibit 99.1. | v343550_8k.htm |
| 2013-03-08 | 8-K | 2013-03-05 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 5, 2013, Elisha W. Finney informed the Board of Directors (the “Board”) of Thoratec Corporation (the “Company”), that she would not stand for re-election to the Board due to other professional commitments. | a13-6991_18k.htm |
| 2013-02-05 | 8-K | 2013-02-05 | 2.02 Results of Operations and Financial Condition | 2.02 On February 5, 2013, Thoratec Corporation (the “Company”) issued a press release announcing its fourth quarter ended December 29, 2012 results, the text of which is attached hereto as Exhibit 99.1. | v333916_8-k.htm |